Non-Profit
Filter News
Found 4,938 articles
-
NEA Awards Grants for Eczema Research Totaling Nearly $1 Million
12/12/2023
The National Eczema Association announced the recipients for its 2023 research grants. From both U.S.-based and international applications, the research projects of 18 outstanding investigators were selected, representing grants totaling nearly $1 million.
-
NMDP/Be The Match® PTCy Research Levels the Field between Matched and Mismatched Hematopoietic Cell Transplantation
12/11/2023
Underscoring its commitment to expanding access to cell and gene therapy, NMDP/Be The Match® presented research at the American Society of Hematology Annual Meeting & Exhibition, which demonstrated that the use of post-transplant cyclophosphamide based graft-versus-host disease prevention significantly reduces the risk of transplant across the human leukocyte antigen barrier and has the potential to level the playing field for patients with mismatched donors.
-
Real World Data Shows Impact of Immunotherapy in Populations Underrepresented in Clinical Trials, According to JNCCN Study
12/11/2023
New research in the December 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds patients treated with first-line immunotherapy for advanced Non-Small Cell Lung Cancer showed similar results in terms of survival, progression-free survival, and treatment duration, regardless of race or ethnicity, even with differences in income and insurance.
-
The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards
12/11/2023
The Leukemia & Lymphoma Society recognized and celebrated the outstanding contributions of five scientific investigators for their achievements in helping drive forward LLS's work to cure blood cancers and improve the quality of life of patients and their families.
-
Lessons Learned From ADLM's COVID Immunity Study Could Improve Research on Future Pandemics
12/7/2023
A special report published in the Association for Diagnostics & Laboratory Medicine's The Journal of Applied Laboratory Medicine describes the design, operations, and methodology of the COVID Immunity Study, a large-scale scientific study by ADLM that took place in September 2021.
-
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
11/28/2023
Charles River Laboratories International, Inc. (NYSE: CRL) and Genetic Cures for Kids Inc today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration.
-
Genethon Using Artificial Intelligence to Improve Effectiveness of Gene Therapies and Patient Access
11/27/2023
Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association, provided an update on its efforts to employ Artificial Intelligence in revolutionizing the development and bioproduction of gene therapies.
-
Debbie's Dream Foundation Helps Light Up More Than 175 Monuments Worldwide with Gastric Cancer Awareness Day Campaign
11/24/2023
As Gastric Cancer Awareness Month unfolds, Debbie's Dream Foundation: Curing Stomach Cancer (DDF) proudly announces a monumental achievement in partnership with My Gut Feeling Stomach Cancer Foundation of Canada (MGF).
-
The Paul G. Allen Family Foundation awards $10.5 million to new Allen Distinguished Investigators
11/21/2023
Uncovering biological properties of extracellular vesicles, which play a vital role in how cells communicate, and understanding how sex hormones drive behavior and development are two areas that the new cohorts of Allen Distinguished Investigators will research, thanks to over $10 million in funding from the Paul G.
-
Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)
11/20/2023
Battelle, Andelyn Biosciences, Inc. , and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to manufacture suspension process gene therapy for the transformative treatment of Aspartylglucosaminuria (AGU).
-
Inteleos Appoints Taryn Reed as Chief Experience Officer
11/20/2023
Inteleos, a leading global nonprofit healthcare organization, welcomes Taryn Reed as its new Chief Experience Officer.
-
Genethon Announces Publication in The Lancet Neurology of Clinical Trial Results of a Gene Therapy for Myotubular Myopathy, a Severe Muscle Disease
11/17/2023
Genethon today announced The Lancet Neurology published online preliminary results of a clinical trial conducted by Astellas Pharma using a gene therapy developed by Genethon for X-linked myotubular myopathy, a rare genetic muscle disease affecting 1 in 50,000 newborn boys.
-
Orion Research Foundation grants EUR 1,112,000 for research in 2024
11/15/2023
Orion Research Foundation sr is distributing EUR 1,112,000 in research grants based on applications for 2024.
-
Social media campaigns may have been one factor that prompted Johnson & Johnson and Danaher to make a TB treatment and a test more accessible in low- and middle-income countries.
-
American Brain Tumor Association Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research
11/8/2023
The American Brain Tumor Association announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages.
-
Helix and Cone Health Launch Population Genomics Initiative
11/7/2023
The hope has always been that genetic testing can lead to not only better health care but also to preventing many health problems in the first place.
-
The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks
11/2/2023
The Multiple Myeloma Research Foundation announced the recipients of three $7 million MMRF Myeloma Accelerator Challenge Program Grants totaling $21 million.
-
The Leukemia & Lymphoma Society Awards $65 Million in New Funding for Blood Cancer Research
11/1/2023
The Leukemia & Lymphoma Society, the largest private funder of blood cancer research, announced $65 million in new grants to 78 research teams across seven countries.
-
Bouwien Smits Joins Civica Rx as Site Vice President and General Manager of New Virginia Manufacturing Facility
11/1/2023
Civica Inc. is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.
-
First Round of Late-Breaking Clinical Trial Results Announced at VIVA23
10/31/2023
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas.